Ting Bao
Auto-generated profile, based on publicly available information

Ting Bao

Dana-Farber Cancer Institute Zakim, Center for Integrative Therapies and Healthy Living, Boston, MA 02215, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
GLGary H. Lyman
Gary H. Lyman
HGHeather Greenlee
Heather Greenlee
KBKari Bohlke
Kari Bohlke
TBTing Bao
Ting Bao
ADAngela M. DeMichele
Angela M. DeMichele
LCLorenzo Cohen
Lorenzo Cohen
Purpose: The Society for Integrative Oncology (SIO) produced an evidence-based guideline on use of integrative therapies during and after breast cancer treatment that was determined to be relevant to the American Society of Clinical Oncology (ASCO) membership. ASCO considered the guideline for endorsement. Methods: The SIO guideline addressed the use of integrative therapies for the management of symptoms and adverse effects, such as anxiety and stress, mood disorders, fatigue, quality of life, chemotherapy-induced nausea and vomiting, lymphedema, chemotherapy-induced peripheral neuropathy, pain, and sleep disturbance. Interventions of interest included mind and body practices, natural products, and lifestyle modifications. SIO systematic reviews focused on randomized controlled trials that were published from 1990 through 2015. The SIO guideline was reviewed by ASCO content experts for clinical accuracy and by ASCO methodologists for developmental rigor. On favorable review, an ASCO Expert Panel was convened to review the guideline contents and recommendations. Results: The ASCO Expert Panel determined that the recommendations in the SIO guideline—published in 2017—are clear, thorough, and based on the most relevant scientific evidence. ASCO endorsed the guideline with a few added discussion points. Recommendations: Key recommendations include the following: Music therapy, meditation, stress management, and yoga are recommended for anxiety/stress reduction. Meditation, relaxation, yoga, massage, and music therapy are recommended for depression/mood disorders. Meditation and yoga are recommended to improve quality of life. Acupressure and acupuncture are recommended for reducing chemotherapy-induced nausea and vomiting. Acetyl-l-carnitine is not recommended to prevent chemotherapy-induced peripheral neuropathy because of a possibility of harm. No strong evidence supports the use of ingested dietary supplements to manage breast cancer treatment–related adverse effects. Additional information is available at: www.asco.org/supportive-care-guidelines .

1 December 2022 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
JMJun J Mao
Jun J Mao
NINofisat Ismaila
Nofisat Ismaila
TBTing Bao
Ting Bao
DBDebra Barton
Debra Barton
EBEran Ben-Arye
Eran Ben-Arye
Eduardo BrueraEduardo Bruera
Eduardo Bruera
PURPOSE: The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other health care providers on integrative approaches to managing pain in patients with cancer. METHODS: The Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included pain intensity, symptom relief, and adverse events. Expert panel members used this evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS: The literature search identified 227 relevant studies to inform the evidence base for this guideline. RECOMMENDATIONS: Among adult patients, acupuncture should be recommended for aromatase inhibitor–related joint pain. Acupuncture or reflexology or acupressure may be recommended for general cancer pain or musculoskeletal pain. Hypnosis may be recommended to patients who experience procedural pain. Massage may be recommended to patients experiencing pain during palliative or hospice care. These recommendations are based on an intermediate level of evidence, benefit outweighing risk, and with moderate strength of recommendation. The quality of evidence for other mind-body interventions or natural products for pain is either low or inconclusive. There is insufficient or inconclusive evidence to make recommendations for pediatric patients. More research is needed to better characterize the role of integrative medicine interventions in the care of patients with cancer. Additional information is available at https://integrativeonc.org/practice-guidelines/guidelines and www.asco.org/survivorship-guidelines .

1 May 2011 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
SCSaranya Chumsri
Saranya Chumsri
THTimothy Howes
Timothy Howes
TBTing Bao
Ting Bao
GSGauri Sabnis
Gauri Sabnis
ABAngela Brodie
Angela Brodie

10 August 2016 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
TBTing Bao
Ting Bao
CBCoby Basal
Coby Basal
CSChristina Seluzicki
Christina Seluzicki
SLSusan Q. Li
Susan Q. Li
ASAndrew D. Seidman
Andrew D. Seidman
JMJun J. Mao
Jun J. Mao

21 May 2015 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
JEJeanette Ezzo
Jeanette Ezzo
EMEric Manheimer
Eric Manheimer
MMMargaret McNeely
Margaret McNeely
Doris HowellDoris Howell
Doris Howell
RWRobert Weiss
Robert Weiss
DKDidem Karadibak
Didem Karadibak

20 April 2021 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
DHDavid Hui
David Hui
KBKari Bohlke
Kari Bohlke
TBTing Bao
Ting Bao
TCToby C. Campbell
Toby C. Campbell
PCPatrick J. Coyne
Patrick J. Coyne
MCMargaret L. Campbell
Margaret L. Campbell
PURPOSE: To provide guidance on the clinical management of dyspnea in adult patients with advanced cancer.METHODS: ASCO convened an Expert Panel to review the evidence and formulate recommendations. An Agency for Healthcare Research and Quality (AHRQ) systematic review provided the evidence base for nonpharmacologic and pharmacologic interventions to alleviate dyspnea. The review included randomized controlled trials (RCTs) and observational studies with a concurrent comparison group published through early May 2020. The ASCO Expert Panel also wished to address dyspnea assessment, management of underlying conditions, and palliative care referrals, and for these questions, an additional systematic review identified RCTs, systematic reviews, and guidelines published through July 2020.RESULTS: The AHRQ systematic review included 48 RCTs and two retrospective cohort studies. Lung cancer and mesothelioma were the most commonly addressed types of cancer. Nonpharmacologic interventions such as fans provided some relief from breathlessness. Support for pharmacologic interventions was limited. A meta-analysis of specialty breathlessness services reported improvements in distress because of dyspnea.RECOMMENDATIONS: A hierarchical approach to dyspnea management is recommended, beginning with dyspnea assessment, ascertainment and management of potentially reversible causes, and referral to an interdisciplinary palliative care team. Nonpharmacologic interventions that may be offered to relieve dyspnea include airflow interventions (eg, a fan directed at the cheek), standard supplemental oxygen for patients with hypoxemia, and other psychoeducational, self-management, or complementary approaches. For patients who derive inadequate relief from nonpharmacologic interventions, systemic opioids should be offered. Other pharmacologic interventions, such as corticosteroids and benzodiazepines, are also discussed. Additional information is available at www.asco.org/supportive-care-guidelines .